> top > docs > PubMed:32560744 > spans > 630-897 > annotations

PubMed:32560744 / 630-897 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-OGER-BB

Id Subject Object Predicate Lexical cue
T2 230-236 CHEBI:36357 denotes agents
T3 230-236 CHEBI:36357 denotes agents
T4 258-266 SP_7 denotes COVID-19

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 60-63 Body_part denotes arm http://purl.org/sig/ont/fma/fma24890

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 60-63 Body_part denotes arm http://purl.obolibrary.org/obo/UBERON_0001460

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T2 258-266 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T7 30-31 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T8 60-63 http://www.ebi.ac.uk/efo/EFO_0001410 denotes arm
T9 94-99 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T10 188-196 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T4 94-99 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T5 128-130 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T7 0-267 Sentence denotes TRIAL DESIGN: AGILE-ACCORD is a Bayesian multicentre, multi-arm, multi-dose, multi-stage open-label, adaptive, seamless phase I/II randomised platform trial to determine the optimal dose, activity and safety of multiple candidate agents for the treatment of COVID-19.

chenxin_473849_800_3

Id Subject Object Predicate Lexical cue
T1 258-266 DP denotes COVID-19

yangbin123xm_800_3

Id Subject Object Predicate Lexical cue
T2 258-266 DP denotes COVID-19